IT7926603A0 - Difenilbutilpiperazincarbossammidi, loro sali di addizione con acidi e composizioni farmaceutiche; procedimenti di fabbricazione ed uso. - Google Patents

Difenilbutilpiperazincarbossammidi, loro sali di addizione con acidi e composizioni farmaceutiche; procedimenti di fabbricazione ed uso.

Info

Publication number
IT7926603A0
IT7926603A0 IT7926603A IT2660379A IT7926603A0 IT 7926603 A0 IT7926603 A0 IT 7926603A0 IT 7926603 A IT7926603 A IT 7926603A IT 2660379 A IT2660379 A IT 2660379A IT 7926603 A0 IT7926603 A0 IT 7926603A0
Authority
IT
Italy
Prior art keywords
diphenylbutylpiperazincarboxamides
manufacturing
pharmaceutical compositions
addition salts
use procedures
Prior art date
Application number
IT7926603A
Other languages
English (en)
Other versions
IT1207269B (it
Inventor
Anders Karl Konrad Bjork
Knut Gunnar Olsson
Aina Lisbeth Abramo
Erik Gunnar Christensson
Original Assignee
Ferrosan Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferrosan Ab filed Critical Ferrosan Ab
Publication of IT7926603A0 publication Critical patent/IT7926603A0/it
Application granted granted Critical
Publication of IT1207269B publication Critical patent/IT1207269B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/215—Radicals derived from nitrogen analogues of carbonic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/194—Radicals derived from thio- or thiono carboxylic acids
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L1/00—Enclosures; Chambers
    • B01L1/52—Transportable laboratories; Field kits

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
IT7926603A 1978-10-20 1979-10-18 Difenilbutilpiperazincarbossammidi, loro sali di addizione con acidi e composizioni farmaceutiche; procedimenti di fabbricazione ed uso. IT1207269B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7810971 1978-10-20

Publications (2)

Publication Number Publication Date
IT7926603A0 true IT7926603A0 (it) 1979-10-18
IT1207269B IT1207269B (it) 1989-05-17

Family

ID=20336152

Family Applications (1)

Application Number Title Priority Date Filing Date
IT7926603A IT1207269B (it) 1978-10-20 1979-10-18 Difenilbutilpiperazincarbossammidi, loro sali di addizione con acidi e composizioni farmaceutiche; procedimenti di fabbricazione ed uso.

Country Status (21)

Country Link
US (3) US4308387A (it)
JP (1) JPS5557572A (it)
AT (1) AT376666B (it)
AU (1) AU529260B2 (it)
BE (1) BE879528A (it)
CA (1) CA1130807A (it)
CH (1) CH643247A5 (it)
DE (1) DE2941880A1 (it)
DK (1) DK149057C (it)
ES (1) ES485188A1 (it)
FI (1) FI73986C (it)
FR (1) FR2439187A1 (it)
GB (1) GB2037745B (it)
HK (1) HK57184A (it)
IT (1) IT1207269B (it)
LU (1) LU81807A1 (it)
NL (2) NL190160C (it)
NO (1) NO154582C (it)
NZ (1) NZ191867A (it)
SE (1) SE448730B (it)
SG (1) SG7384G (it)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE791501A (fr) * 1971-11-19 1973-05-17 Albert Ag Chem Werke Diamines cycliques n,n'-disubstituees et leur procede de preparation
US4492698A (en) * 1980-06-16 1985-01-08 Bjoerk Anders K Diphenylbutyl-1-acylpiperazines
AU562546B2 (en) * 1981-12-02 1987-06-11 Ferrosan A.B. 1-piperazinocarboxylates, process for their preparation and pharmaceutical compositions containing them
US4543352A (en) * 1983-04-29 1985-09-24 William H. Rorer, Inc. Naphthalene aminoalkylene ethers and thioethers, and their pharmaceutical uses
AT387572B (de) * 1983-05-20 1989-02-10 Ferrosan Ab Verfahren zur herstellung von neuen 4-(4,4-bis-(p-fluorphenyl)-butyl)-1-carbophenox -piperazinen und von 1-piperazincarboxamiden
ES8502099A1 (es) 1983-08-02 1984-12-16 Espanola Farma Therapeut Procedimiento de obtencion de nuevos compuestos derivados de la difenil-metilen-etilamina.
SE8304361D0 (sv) * 1983-08-10 1983-08-10 Ferrosan Ab Novel 1-acylpiperazine derivatives novel 1-acylpiperazine derivatives
FR2558162B1 (fr) * 1984-01-17 1986-04-25 Adir Nouveaux derives de la xanthine, leurs procedes de preparation et les compositions pharmaceutiques les renfermant
SE8500573D0 (sv) * 1985-02-08 1985-02-08 Ferrosan Ab Novel piperazinecarboxamides having a phenoxyalkyl or thiophenoxyalkyl side chain
US4960776A (en) * 1987-01-28 1990-10-02 A. H. Robins Company, Inc. 4-aryl-N-(alkylaminoalkyl, heterocyclicamino and heterocyclicamino)alkyl)-1-piperazinecarboxamides
WO1990013539A1 (fr) * 1989-04-28 1990-11-15 Meiji Seika Kaisha, Ltd. Nouveaux derives de piperazine a substitution n et medicament de traitement des troubles fonctionnels du cerveau
FR2673182A1 (fr) * 1991-02-22 1992-08-28 Univ Caen Piperazines n,n'-disubstituees, leur procede de preparation et leur application en therapeutique.
SE9100860D0 (sv) * 1991-03-22 1991-03-22 Kabi Pharmacia Ab New use
SE9201239D0 (sv) * 1992-04-21 1992-04-21 Kabi Pharmacia Ab Agents for treating substance abuse disorders
DE4219973A1 (de) * 1992-06-19 1993-12-23 Basf Ag N-substituierte Azabicycloheptan-Derivate, ihre Herstellung und Verwendung
SE9202266D0 (sv) * 1992-07-31 1992-07-31 Kabi Pharmacia Ab Novel piperazine carboxamides
DE4307181C1 (de) * 1993-03-08 1994-11-10 Dresden Arzneimittel Verfahren zur Herstellung von 5H-Dibenz/b,f/azepin-5-carboxamid
DE4341403A1 (de) * 1993-12-04 1995-06-08 Basf Ag N-substituierte 3-Azabicycloalkan-Derivate, ihre Herstellung und Verwendung
JP3274579B2 (ja) * 1995-01-12 2002-04-15 住友製薬株式会社 脳血管障害に伴う精神症候治療剤
DE29815747U1 (de) 1998-09-02 2000-01-05 Ramsauer, Dieter, 42555 Velbert Anschraubscharnier mit Raststellung
GB9923748D0 (en) * 1999-10-07 1999-12-08 Glaxo Group Ltd Chemical compounds
USRE39921E1 (en) 1999-10-07 2007-11-13 Smithkline Beecham Corporation Chemical compounds
GB0025354D0 (en) * 2000-10-17 2000-11-29 Glaxo Group Ltd Chemical compounds
GB0108594D0 (en) * 2001-04-05 2001-05-23 Glaxo Group Ltd Chemical compounds
US20030068375A1 (en) 2001-08-06 2003-04-10 Curtis Wright Pharmaceutical formulation containing gelling agent
US7332182B2 (en) 2001-08-06 2008-02-19 Purdue Pharma L.P. Pharmaceutical formulation containing opioid agonist, opioid antagonist and irritant
US7157103B2 (en) 2001-08-06 2007-01-02 Euro-Celtique S.A. Pharmaceutical formulation containing irritant
US7141250B2 (en) * 2001-08-06 2006-11-28 Euro-Celtique S.A. Pharmaceutical formulation containing bittering agent
US20030044458A1 (en) * 2001-08-06 2003-03-06 Curtis Wright Oral dosage form comprising a therapeutic agent and an adverse-effect agent
US7842307B2 (en) * 2001-08-06 2010-11-30 Purdue Pharma L.P. Pharmaceutical formulation containing opioid agonist, opioid antagonist and gelling agent
GB0203020D0 (en) * 2002-02-08 2002-03-27 Glaxo Group Ltd Chemical compounds
JP2005522436A (ja) * 2002-02-08 2005-07-28 グラクソ グループ リミテッド ピペリジルカルボキシアミド誘導体またはそのタキキニン介在疾患の治療における使用
GB0203022D0 (en) * 2002-02-08 2002-03-27 Glaxo Group Ltd Chemical compounds
ES2653568T3 (es) 2004-06-12 2018-02-07 Collegium Pharmaceutical, Inc. Formulaciones de fármacos para la prevención del abuso
JP4823673B2 (ja) * 2005-12-15 2011-11-24 タカラベルモント株式会社 ショックレス弁を接続した油圧回路
JP2010169206A (ja) * 2009-01-23 2010-08-05 Finesinter Co Ltd ノンリークショックレス電磁比例制御弁
US10668060B2 (en) 2009-12-10 2020-06-02 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
PL2826467T3 (pl) 2010-12-22 2018-01-31 Purdue Pharma Lp Zamknięte, zabezpieczone przed manipulowaniem formy dozowania o kontrolowanym uwalnianiu
PH12013501345A1 (en) 2010-12-23 2022-10-24 Purdue Pharma Lp Tamper resistant solid oral dosage forms
PE20151301A1 (es) 2013-02-05 2015-09-16 Purdue Pharma Lp Formulaciones farmaceuticas resistentes a la manipulacion indebida
US10751287B2 (en) 2013-03-15 2020-08-25 Purdue Pharma L.P. Tamper resistant pharmaceutical formulations
US9737530B1 (en) 2016-06-23 2017-08-22 Collegium Pharmaceutical, Inc. Process of making stable abuse-deterrent oral formulations

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL137318C (it) * 1964-06-09
JPS518283A (en) * 1974-07-09 1976-01-23 Kyorin Seiyaku Kk 11 * 33 fuenirupuropiru * 44 karubamoirupiperajinjudotaino seizoho
JPS5346988A (en) * 1976-10-07 1978-04-27 Kyorin Seiyaku Kk Piperadine derivative

Also Published As

Publication number Publication date
GB2037745A (en) 1980-07-16
CH643247A5 (de) 1984-05-30
AU529260B2 (en) 1983-06-02
NO154582C (no) 1986-11-05
SG7384G (en) 1985-02-08
NL190160C (nl) 1993-11-16
BE879528A (fr) 1980-04-21
NO793315L (no) 1980-04-22
NZ191867A (en) 1983-06-14
NL7907741A (nl) 1980-04-22
GB2037745B (en) 1982-11-24
US4385057A (en) 1983-05-24
JPS6326756B2 (it) 1988-05-31
AT376666B (de) 1984-12-27
US4447433A (en) 1984-05-08
NO154582B (no) 1986-07-28
FR2439187B1 (it) 1983-03-18
NL940004I1 (nl) 1994-05-02
AU5198479A (en) 1980-06-19
JPS5557572A (en) 1980-04-28
DK149057B (da) 1986-01-06
DE2941880C2 (it) 1989-04-20
CA1130807A (en) 1982-08-31
ES485188A1 (es) 1980-05-16
FI793238A7 (fi) 1980-04-21
NL190160B (nl) 1993-06-16
DK149057C (da) 1986-06-02
FI73986C (fi) 1987-12-10
SE7908701L (sv) 1980-04-21
FR2439187A1 (fr) 1980-05-16
DK442779A (da) 1980-04-21
SE448730B (sv) 1987-03-16
IT1207269B (it) 1989-05-17
LU81807A1 (de) 1980-01-25
HK57184A (en) 1984-08-03
ATA683479A (de) 1984-05-15
DE2941880A1 (de) 1980-04-30
US4308387A (en) 1981-12-29
FI73986B (fi) 1987-08-31

Similar Documents

Publication Publication Date Title
IT8220611A0 (it) Composizioni farmaceutiche topiche.
IT8022284A0 (it) N-aril-ossazolidinoni e -pirrolidinoni, e procedimenti per la loro preparazione.
IT1194900B (it) N-(fenossialchile)immidazoli,relative composizioni farmaceutiche e procedimento per la loro fabbricazione
FI830360A7 (fi) Paikallisia farmaseuttisia koostumuksia.
BE852445A (fr) Nouvelles compositions pharmaceutiques anti-inflammatoires
FI803508A7 (fi) Menetelmä imidatsoli-5- etikkahappojohdannaisten valmistamiseksi.
IT8024310A0 (it) Sali della (+)-catechina, loro preparazione e loro impiego e anche composizioni che contengono questi sali.
NO157979C (no) Analogifremgangsmaate for fremstilling av nye, terapeutisk aktive benzotiazindioksyd-salter.
IT7925061A0 (it) Sali di coloranti basici, loro preparazione ed impieghi.
FI802228A7 (fi) Uudet karboksyylihappojohdokset, niiden valmistaminen ja niiden käyttö.
NL7901070A (nl) Prostacycline-derivaten.
IT7949927A0 (it) Imidazochinossaline e loro sali,loro procedimento di produzione,loro impiego come medicamenti e composizioni farmaceutiche che le contengono
IT1207271B (it) Amminoglicosidi, procedimento per la loro preparazione e loro impiego.
IT7921290A0 (it) Analoghi di cefalosporina eprocedimento per la loro preparazione.
IT7927243A0 (it) Per la loro preparazione e composti triazinonici, procedimenti composizioni farmaceutiche che licontengono.
FI792850A7 (fi) Auronijohdannaisia.
IT7925387A0 (it) 2-amminoetil-1-fenil-indoline, loro preparazione e loro applicazione come medicamenti.
IT7829507A0 (it) Arileteri delle n-alchil-piperidine e loro sali di addizione con acidi.
FI834663A0 (fi) Substituerade azabicycloalkaner, deras anvaendning, dessa foereningar innehaollande farmaceutiska preparat och foerfarande foer framstaellning av dessa foereningar
IT8025577A0 (it) Composizione farmaceutica ad azione prolungata.
FI792564A7 (fi) Hydroksietikkahappojohdannaisia.
IT1070097B (it) Diidromicina e suoi sali come antibiotici particolarmente per uso zootecnico...e procedimento per la loro preparazione
FI802009A7 (fi) Asyyliaminobentsoehappojohdannaiset.
IT8347702A0 (it) Alcaloidi ergopeptidici, loro preparazione e loro impiego come medicamenti
BE892709A (fr) Nouvelles compositions pharmaceutiques topiques

Legal Events

Date Code Title Description
ITCP Complementary protection certificate

Free format text: CCP 358

MEDD Supplementary protection certificate for pharmaceutical products: granted

Free format text: CCP 358, 19920518; KABI PHARMACIA AB

TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19971030